Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 4,661,000 | 4,146,000 | 4,500,000 | 4,709,000 | 4,689,000 |
| Cost of Goods | 1,502,000 | 1,568,000 | 1,317,000 | 1,347,000 | 1,283,000 |
| Gross Profit | 3,159,000 | 2,578,000 | 3,183,000 | 3,362,000 | 3,406,000 |
| Operating Expenses | 1,872,000 | 5,033,000 | 1,673,000 | 1,861,000 | 1,719,000 |
| Operating Income | 1,287,000 | -2,455,000 | 1,510,000 | 1,501,000 | 1,687,000 |
| Other Income | -59,000 | -73,000 | 93,000 | 0 | 0 |
| Pre-tax Income | 1,228,000 | -2,528,000 | 1,603,000 | 1,501,000 | 1,687,000 |
| Income Tax | 333,000 | -1,015,000 | 385,000 | 399,000 | 444,000 |
| Net Income Continuous | 842,000 | -1,647,000 | 1,173,000 | 1,102,000 | 1,243,000 |
| Net Income Discontinuous | 14,000 | 2,585,000 | 14,000 | 99,000 | 93,000 |
| Net Income | $856,000 | $938,000 | $1,187,000 | $1,201,000 | $1,336,000 |
| EPS Basic Total Ops | 0.44 | 0.48 | 0.61 | 0.62 | 0.69 |
| EPS Basic Continuous Ops | 0.43 | -0.85 | 0.60 | 0.57 | 0.64 |
| EPS Basic Discontinuous Ops | 0.01 | 1.33 | 0.01 | 0.05 | 0.05 |
| EPS Diluted Total Ops | 0.44 | 0.47 | 0.61 | 0.61 | 0.68 |
| EPS Diluted Continuous Ops | 0.43 | -0.84 | 0.60 | 0.56 | 0.63 |
| EPS Diluted Discontinuous Ops | 0.01 | 1.31 | 0.01 | 0.05 | 0.05 |
| EBITDA(a) | $1,466,000 | $-2,227,000 | $1,647,000 | $1,679,000 | $1,872,000 |